Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

A picture of radiologists looking at a screen showing the restaging of the HNSCC

Study Highlights the Potential of Radiomics in Medical Intervention

A recent study conducted by the Medical University of Innsbruck highlights the potential of radiomics in exploring the impacts of Radiochemotherapy (RCT) on patients with Head and Neck Squamous Cell Carcinoma (HNSCC). This study is the first to explore short-term RCT-induced skeletal muscle alterations after RCT in HNSCC patients applying radiomics, a data-driven approach aiming at extracting and processing quantitative data to analyze image-based information.

With the help of the mint Lesion™ Radiomics module, the research examined radiation-induced changes in the sternocleidomastoideus muscle (SCM) and paravertebral musculature (PVM) post-RCT. Analyzing key radiomic features like volume, mean positivity of pixels, and uniformity the study team was able to confirm the optimal window of 6 to 12 weeks for salvage surgery post-RCT, minimizing the risk of complications due to tissue fibrosis. These findings further showcase how radiomics can enhance medical treatment strategies and indicate a bright path for ongoing research in this area.

Read more about the study

Related Resources

Related Resources

How mint Lesion 3.5 helps you to benefit from Artificial Intelligence in Radiology

According to researchers, every adult makes 35,000 decisions each day. While there are no numbers in literature about how many decisions a radiologist…

MROC: The Impact of mpMRI on the Staging and Management of Patients with Suspected or Confirmed OC

Funded by the National Institute of Health Research (NIHR) and sponsored by the Imperial College London, the MROC study boasts impressive figures: 645…

AI-powered quantification of bone metastasis in prostate cancer

Prostate cancer is the second most common cancer among men, and there are now effective treatments for the disease. New therapies available on the…